Extendicare (TSE:EXE – Get Rating) had its price objective lifted by National Bankshares from C$7.00 to C$7.50 in a report published on Tuesday morning, BayStreet.CA reports. National Bankshares currently has a sector perform rating on the stock.
Separately, Royal Bank of Canada cut their price target on shares of Extendicare from C$7.50 to C$7.00 and set a sector perform rating on the stock in a report on Monday, March 6th.
Extendicare Stock Up 4.0 %
Shares of TSE EXE opened at C$7.00 on Tuesday. The company has a debt-to-equity ratio of 381.30, a current ratio of 0.94 and a quick ratio of 0.98. Extendicare has a one year low of C$6.02 and a one year high of C$7.69. The stock has a market capitalization of C$593.11 million, a P/E ratio of -140.00 and a beta of 1.20. The firm’s 50 day simple moving average is C$6.42 and its two-hundred day simple moving average is C$6.61.
Extendicare Dividend Announcement
The company also recently disclosed a monthly dividend, which will be paid on Thursday, June 15th. Shareholders of record on Wednesday, May 31st will be given a dividend of $0.04 per share. This represents a $0.48 annualized dividend and a yield of 6.86%. The ex-dividend date is Tuesday, May 30th. Extendicare’s dividend payout ratio is currently -960.00%.
About Extendicare
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties.
Featured Stories
- How to Buy Southwest Airlines Stock
- Lucid Group Bottomed, But The Outlook Remains Cloudy
- Shoals Technology is an EV and Solar Play Just Getting Started
- Under Armour May Have Just Bottomed
- Skyworks Solutions: Another Crack in the Consumer Outlook
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.